History of Corona Virus and COVID-19 Antibody Testing
Corona Virus is a respiratory disease caused by a new virus. it seemed to hit us very suddenly back in February. The symptoms include fever, sore throat, and shortness of breath. It is highly contagious and spreads quickly from person to person. This is because we have no immunity to the new strain of infection. It is important to keep washing your hands and use hand sanitizer to prevent it from spreading. The experts argue that there is more than one type of coronavirus, the one that causes a mild cold and a severe one including Severe Acute Respiratory Syndrome and another one Middle East Respiratory Syndrome or MERS. The new coronavirus originated in China and is named Covid-19.
We all know the sad reality that we live today under the COVID-19 pandemic, and we also know the importance of tests to detect this disease. Having the ability to know who has the virus and who is not infected has become vital information for all parts of the planet.
Most current COVID-19 tests involve a nasal swab sample or blood sample to determine if a person is infected with the virus. Those swabs and samples are analyzed, often by a laboratory process called the Polymerase Chain Reaction (PCR) to find the virus.
Now researchers are also interested in developing a type of analysis known as a serological test. This type of test involves analyzing blood samples to see the patient’s immune response to the virus.
But a serological test could instead determine who has already had the virus or been exposed to it by looking for a person’s antibody levels. Although experts continue to examine whether people who have recovered from the disease can get it again.
The ability to detect antibodies to SARS-CoV-2 lets you know if someone had COVID-19 coronavirus disease, even if they have never been diagnosed or shown signs of the condition.
Why are antibodies so important?
As a first point, the serological test reveals whether or not the person developed immunity against COVID-19. The researchers have not yet determined whether people recovered from COVID-19 are protected and can no longer become infected again.
To understand the immunity of people who have already overcome COVID-19, it should be borne in mind that generally, the immune system defends itself against viral infection in two phases: innate immunity, prepared against any aggression, and adaptive immunity that attacks specific pathogens.
Among the adaptive immunity are the antibodies that recognize specific viruses and know how to fight them. Therefore, the search for antibodies is important to detect the immunity of the individual.
It appears that this may well be the case, based on anecdotal evidence from China, preliminary studies in model animals, and experience gained from previous outbreaks, such as acute and severe respiratory syndrome and respiratory syndrome in the Middle East.
By having a serological test, there would possibly be an opportunity to know whether, for example, health personnel has developed an immunity. Although they would still be required to wear personal protective equipment, the risk that they would become infected again would be less than that of healthcare personnel who lack such immunity.
Even if blood tests are not used for the initial diagnosis, large-scale serological tests can provide critical information to discover where the disease was and to predict what future high activity areas will be.
Although the virus may no longer be detectable in some people, confirming the exposure of a certain population allows knowing which geographic areas are vulnerable and which are not.
Serological tests will contribute to expanding the areas of diagnosis, treatment, and research of COVID-19.
Researchers will want to use them to learn more about timing, for example: how long after infection do patients develop antibodies to COVID-19, and how long do those antibodies last in the body?
That information may help track the progression of the disease and allow for the development and programming of a possible vaccine. Ultimately, serology will provide a vital means of tracking and coping with the pandemic.
Where to get a coronavirus testing near me?
If you know someone or think you have COVID-19, you must carry out a test to verify if you have the virus. The symptoms of coronavirus are:
· Dry cough
· Loss of taste and smell
· Sore throat
· Difficulty breathing
If you have several of these symptoms, you can calmly call 911 and notify that you have a possible case of COVID-19, so they can inform you of the closest site so that you can perform the test.
If you are specifically looking for a Corona Virus testing Pennsylvania, Safe Care Express Urgent Care offers you the best medical services. If you suspect that you are a carrier of the virus, you can go to their clinic to receive the best care.
It is important that if you plan to go or are on your way to the Safe Care Express Clinic, call ahead so they are ready to meet you.
You can find more information about this COVID-19 Antibody Testing / Corona Virus testing site at www.safecarexpress.com.
Antibodies related tests
Many experts hope that people who have recovered from the virus will be immune for some time. That is why many countries are preparing to invest in antibody tests to determine what proportion of their population may be immune to the virus.
Some laboratory companies in Europe and the United States have just started rolling out commercial versions of these tests that will likely be more available in the coming weeks.
The United States Food and Drug Administration recently issued its first authorization for an antibody blood test.
In Munich (Germany), the journal Nature has presented an immunity study involving 9 patients from the Munich University Hospital, which revealed that the appearance of the antibodies occurs between 6 and 14 days after the onset of symptoms.
Other experiments in Australia and China have shown that the antibodies remain after the COVID-19 virus infection is cured.
In Spain, the Ministry of Health has announced that it has already launched an investigation that consists of detecting the number of people immunized against the coronavirus employing antibody tests.
This is reassuring news for governments that intend to implement COVID-19 Antibody Testing to restore normality to society. However, increasing production fast enough to meet the needs of governments “is not a feat.”
Diagnostic companies may be better positioned to meet demand, but it is an effort. For the most part, these companies are focusing their production on these tests.
Many scientific studies have determined that once social distancing restrictions are lifted, cases could go up again, but if many people have developed antibodies to the virus, this could prevent a second epidemic wave.